Targeting lung cancer: synergistic therapeutic strategy of cuproptosis and immunogenic cell death
Frontiers in Cell and Developmental Biology · 04.05.2026 · 14
DOI: 10.3389/fcell.2026.1732351 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Cell and Developmental Biology, online erschienen am 04.05.2026. Verfasst von Yan Yang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Hunan University of Chinese Medicine, Changsha, China. Die Arbeit nennt 144 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Cu, a common essential trace element in the human body, is involved in multiple physiological and pathological processes. Cuproptosis, a recently proposed form of cell death, is triggered by Cu overload. It primarily targets lipoylated proteins in the tricarboxylic acid cycle, induces proteotoxic stress, and impairs mitochondrial respiration. Cuproptosis can induce immunogenic cell death (ICD), which triggers adaptive immunity in response to cellular stress, thereby stimulating an immune response. Conversely, ICD may also induce cuproptosis, indicating an interaction between the two; this mechanism should provide insights in lung cancer treatment. Lung cancer is a common disease that endangers human health and is characterized by high mortality and incidence rates. Despite the availability of therapeutic regimens such as surgery, radiotherapy, chemotherapy, and immune checkpoint inhibitors, their prognosis remains controversial. This review innovatively proposes that the combination of these two forms of cell death, together with their interaction, may target biomarkers of various lung cancers. This study provides a theoretical basis for addressing the challenges encountered in lung cancer treatment.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Hunan University of Chinese Medicine, Changsha, China.
- Yueyang County Health Bureau, Yueyang, China.
Zitieren
APA
Yang, Y., Pei, W., Ren, T., Wang, Y., Dai, L., Maimaitiaili, B., Meng, B., Tang, Q., & Feng, H. (2026). Targeting lung cancer: synergistic therapeutic strategy of cuproptosis and immunogenic cell death. Frontiers in Cell and Developmental Biology, 14. https://doi.org/10.3389/fcell.2026.1732351
Vancouver
Yang Y, Pei W, Ren T, Wang Y, Dai L, Maimaitiaili B, et al. Targeting lung cancer: synergistic therapeutic strategy of cuproptosis and immunogenic cell death. Frontiers in Cell and Developmental Biology. 2026;14. doi:10.3389/fcell.2026.1732351
BibTeX
@article{Yang2026,
author = {Yang, Yan and Pei, Wanjuan and Ren, Tao and Wang, Yiru and Dai, Ling and Maimaitiaili, Baierna and Meng, Bin and Tang, Qun and Feng, Huiling},
title = {Targeting lung cancer: synergistic therapeutic strategy of cuproptosis and immunogenic cell death},
journal = {Frontiers in Cell and Developmental Biology},
year = {2026},
volume = {14},
doi = {10.3389/fcell.2026.1732351}
}
EUVIMED